-->

Tag: polatuzumab vedotin FDA approval

Home / polatuzumab vedotin FDA approval

Categories

Polatuzumab vedotin-piiq is approved by USFDA for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

May 2023: For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously received treatment and who have an...
polatuzumab-vedotin-fda-approval

Scan the code